PING for Chronic Disease Management
(PING Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach called Patient-Initiated Note about Goals (PING) to help manage chronic diseases. The researchers aim to determine if patients who actively communicate their health goals with nurses can improve their overall care. Participants will either use PING or receive their usual care. Those scheduled for an Annual Wellness Visit at one of the participating clinics and who speak English might be suitable for the trial. As an unphased study, this trial offers a unique opportunity to actively participate in enhancing the healthcare experience.
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I need to stop taking my current medications for the PING trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the Patient-Initiated Note about Goals (PING) is safe for chronic disease management?
Research has shown that the Patient-Initiated Note about Goals (PING) helps patients share their care goals through electronic health records. Specific safety information about PING for managing chronic diseases is currently unavailable. However, as a communication tool rather than a medication or surgery, PING likely poses a low risk of physical side effects or health issues.
The trial phase is labeled "Not Applicable," indicating that the tool isn't a traditional drug or treatment with major safety concerns. This suggests that PING is considered safe enough to test without the initial safety phases typically required for new drugs or devices.12345Why are researchers excited about this trial?
Researchers are excited about PING for chronic disease management because it empowers patients by allowing them to actively participate in setting and communicating their health goals. Unlike traditional treatments that primarily focus on clinical interventions by healthcare providers, PING offers a unique approach where patients take the initiative to document and share their personal health objectives with their care team. This patient-centered method can lead to more personalized care and potentially improve patient engagement and outcomes. By shifting the focus to what matters most to patients, PING hopes to enhance the effectiveness of chronic disease management.
What evidence suggests that the Patient-Initiated Note about Goals (PING) is effective for chronic disease management?
Research has shown that the Patient-Initiated Note about Goals (PING), which participants in this trial may receive, helps guide care by aligning it with patient preferences. Studies indicate that patients using PING can set clear goals and plan for managing chronic diseases. This tool encourages conversations between patients and healthcare providers about care preferences. Additionally, PING has shown promise in helping patients manage their health conditions by focusing on what matters most to them. It uses digital technologies to boost patient motivation and improve self-care for chronic illnesses.12367
Who Is on the Research Team?
David J Casarett, MD
Principal Investigator
Duke Health
Are You a Good Fit for This Trial?
This trial is for patients who have been referred for an Annual Wellness Visit at a participating clinic. It's specifically designed for English-speaking individuals, as non-English speakers are not eligible to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Patient-Initiated Note about Goals (PING) administered by a registered nurse or usual care
Follow-up
Participants are monitored for subsequent goals of care conversations and healthcare utilization
What Are the Treatments Tested in This Trial?
Interventions
- Patient-Initiated Note about Goals (PING)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor